Aditya Criticare Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 21-12-2024
- Paid Up Capital ₹ 0.40 M
as on 21-12-2024
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.29 Cr
as on 21-12-2024
- Revenue 8.31%
(FY 2021)
- Profit 51.09%
(FY 2021)
- Ebitda -2.27%
(FY 2021)
- Net Worth 47.44%
(FY 2021)
- Total Assets 10.93%
(FY 2021)
About Aditya Criticare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹5.29 Cr.
Sarojini Chinthalapani and Rakesh Chintalapani serve as directors at the Company.
- CIN/LLPIN
U85110TG2013PTC089880
- Company No.
089880
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2013
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aditya Criticare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarojini Chinthalapani  | Director | 03-Jan-2024 | Current |
| Rakesh Chintalapani | Director | 05-Sep-2013 | Current |
Financial Performance of Aditya Criticare.
Aditya Criticare Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 8.31% increase. The company also saw a substantial improvement in profitability, with a 51.09% increase in profit. The company's net worth Soared by an impressive increase of 47.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aditya Criticare?
In 2021, Aditya Criticare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gold Flower Conventions Private LimitedActive 9 years 1 monthRakesh Chintalapani is a mutual person
- Dr Vasavi's Hospital Centre For Fertility & Birth Private LimitedActive 7 years 4 months
Rakesh Chintalapani is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 Feb 2024 | ₹5.00 Cr | Open |
Others Creation Date: 28 Feb 2022 | ₹2.90 M | Open |
How Many Employees Work at Aditya Criticare?
Aditya Criticare has a workforce of 20 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aditya Criticare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aditya Criticare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
